Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...
SAN DIEGO, Feb. 3, 2021 /PRNewswire/ — ViaCyte, Inc., a clinical-stage regenerative medicine company, today announced that the first type 1 diabetes (T1D) patients have been implanted in a Phase 2 ...
A team led by Professor Guosheng Tang from Guangzhou Medical University, Associate Professor Yutao Liu from Tianjin ...
Lipids have become indispensable to modern drug delivery offering a versatile toolkit for the formulation and transport of therapeutic agents. Over the past two decades, the field has experienced ...